Forest Laboratories

Teva to buy Allergan generic drug business for $40.5 billion, drops Mylan bid

Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms.

Read Full Article

Forest Laboratories Considers Bid for Elan Corp

According to sources, Icahn-backed Forest Laboratories is among mid-sized drug makers to eye for Elan.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics